Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearables, Mobile-based Applications, Sensors), By Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), By End-use, By Region, And Segment Forecasts, 2025
Description
Psychiatric Digital Biomarkers Market Trends
The global psychiatric digital biomarkers market size was estimated at USD 631.3 million in 2024 and is projected to grow at a CAGR of 24.4% from 2025 to 2030. The rising prevalence of mental health disorders, advancements in digital health technologies, and growing demand for personalized medicine drive the market. For instance, according to the World Health Organization, approximately 280 million individuals across the globe have depression. Depression is about 50% more common among women than men.
The rising adoption of wearable devices and mobile health apps in mental healthcare contributes to market growth. Moreover, according to the International Data Corporation (IDC), shipments of wearable devices increased by 2.6% across the globe in the third quarter of 2023 compared to the previous year, setting a new third-quarter record with a total of 148.4 million units.
Moreover, the global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of individuals worldwide. In 2023, Mental Health America, Inc. found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing demand for psychiatric digital biomarkers.
Technological advancements in digital health technologies have revolutionized the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual’s mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis. For instance, in September 2022, Feel Therapeutics Inc., a digital biomarkers and therapeutics developer to bring objective data in mental health, introduced the Digital Precision Medicine Platform. With this platform, the company is able to collect clinically valuable data points passively and on a 24/7 basis to generate real-world evidence (RWE) and discover novel digital biomarkers and endpoints.
Global Psychiatric Digital Biomarkers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end-use, and region.
Canada
Mexico
UK
France
Italy
Spain
Denmark
Sweden
Norway
Japan
India
South Korea
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait
The global psychiatric digital biomarkers market size was estimated at USD 631.3 million in 2024 and is projected to grow at a CAGR of 24.4% from 2025 to 2030. The rising prevalence of mental health disorders, advancements in digital health technologies, and growing demand for personalized medicine drive the market. For instance, according to the World Health Organization, approximately 280 million individuals across the globe have depression. Depression is about 50% more common among women than men.
The rising adoption of wearable devices and mobile health apps in mental healthcare contributes to market growth. Moreover, according to the International Data Corporation (IDC), shipments of wearable devices increased by 2.6% across the globe in the third quarter of 2023 compared to the previous year, setting a new third-quarter record with a total of 148.4 million units.
Moreover, the global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of individuals worldwide. In 2023, Mental Health America, Inc. found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing demand for psychiatric digital biomarkers.
Technological advancements in digital health technologies have revolutionized the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual’s mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis. For instance, in September 2022, Feel Therapeutics Inc., a digital biomarkers and therapeutics developer to bring objective data in mental health, introduced the Digital Precision Medicine Platform. With this platform, the company is able to collect clinically valuable data points passively and on a 24/7 basis to generate real-world evidence (RWE) and discover novel digital biomarkers and endpoints.
Global Psychiatric Digital Biomarkers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end-use, and region.
- Type Outlook (Revenue, USD Million, 2018 - 2030)
- Wearable
- Mobile based Applications
- Sensors
- Others
- Clinical Practice Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Psychiatric Digital Biomarkers
- Monitoring Psychiatric Digital Biomarkers
- Predictive and Prognostic Psychiatric Digital Biomarkers
- Others
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Healthcare companies
- Healthcare Providers
- Payers
- Others (Patient, caregivers)
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
Canada
Mexico
- Europe
UK
France
Italy
Spain
Denmark
Sweden
Norway
- Asia Pacific
Japan
India
South Korea
Australia
Thailand
- Latin America
Argentina
- MEA
Saudi Arabia
UAE
Kuwait
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Clinical Practice outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Psychiatric Digital Biomarkers Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Psychiatric Digital Biomarkers: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTLE Analysis
- Chapter 4. Psychiatric Digital Biomarkers Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Type Market Share Analysis, 2024 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Psychiatric Digital Biomarkers Market, by Type, 2018 to 2030
- 4.5. Wearable
- 4.5.1. Wearable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Mobile based Applications
- 4.6.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Sensors
- 4.7.1. Sensors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Others
- 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Psychiatric Digital Biomarkers Market Segment Analysis, By Clinical Practice, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. Clinical Practice Market Share Analysis, 2024 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2018 to 2030
- 5.5. Diagnostic Psychiatric Digital Biomarkers
- 5.5.1. Diagnostic Psychiatric Digital Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Monitoring Psychiatric Digital Biomarkers
- 5.6.1. Monitoring Psychiatric Digital Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Predictive and Prognostic Psychiatric Digital Biomarkers
- 5.7.1. Predictive and Prognostic Psychiatric Digital Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Psychiatric Digital Biomarkers Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 6.1. Definition and Scope
- 6.2. End Use Market Share Analysis, 2024 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Psychiatric Digital Biomarkers Market, by End Use, 2018 to 2030
- 6.5. Healthcare companies
- 6.5.1. Healthcare companies market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Healthcare Providers
- 6.6.1. Healthcare Providers market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Payers
- 6.7.1. Payers market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Psychiatric Digital Biomarkers Market Segment Analysis, By Region, 2018- 2030 (USD Million)
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Psychiatric Digital Biomarkers Market Share by Region, 2024 & 2030:
- 7.5. North America
- 7.5.1. North America psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. U.S. psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Canada psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Mexico psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1. UK psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Germany psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. France psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Italy psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Spain psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Norway psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Sweden psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Denmark psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. China psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. India psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Australia psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. South Korea psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Thailand psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Argentina psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. UAE psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait psychiatric digital biomarkers market, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Koneksa Health
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Biogen
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Empatica Inc
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. VivoSense
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. IXICO plc
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Sonde Health, Inc.
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Clario
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
